Heterogeneous mutation pattern in tumor tissue and circulating tumor DNA warrants parallel NGS panel testing

Liquid biopsy by genotyping circulating tumor DNA (ctDNA) has provided a non-invasive approach in assessing tumor genomic alterations in clinical oncology. However, emerging evidence in clinical settings has shown significant discordance in the genomic alterations between matched tumor tissue and bl...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Qiaomei, Wang, Junlei, Xiao, Jianfeng, Wang, Lin, Hu, Xiaomeng, Yu, Wenjun, Song, Gang, Lou, Jiatao, Chen, JianFeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6114875/
https://www.ncbi.nlm.nih.gov/pubmed/30153823
http://dx.doi.org/10.1186/s12943-018-0875-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6114875/
https://www.ncbi.nlm.nih.gov/pubmed/30153823
http://dx.doi.org/10.1186/s12943-018-0875-0

Ejemplares similares